324 related articles for article (PubMed ID: 29046238)
41. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
[TBL] [Abstract][Full Text] [Related]
42. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
Bekircan O; Küxük M; Kahveci B; Kolayli S
Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis, and evaluation of novel imidazo[1,2-a][1,3,5]triazines and their derivatives as focal adhesion kinase inhibitors with antitumor activity.
Dao P; Smith N; Tomkiewicz-Raulet C; Yen-Pon E; Camacho-Artacho M; Lietha D; Herbeuval JP; Coumoul X; Garbay C; Chen H
J Med Chem; 2015 Jan; 58(1):237-51. PubMed ID: 25180654
[TBL] [Abstract][Full Text] [Related]
44. Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1.
Cheung M; Kuntz KW; Pobanz M; Salovich JM; Wilson BJ; Andrews CW; Shewchuk LM; Epperly AH; Hassler DF; Leesnitzer MA; Smith JL; Smith GK; Lansing TJ; Mook RA
Bioorg Med Chem Lett; 2008 Dec; 18(23):6214-7. PubMed ID: 18929484
[TBL] [Abstract][Full Text] [Related]
45. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities.
Singh S; Mandal MK; Masih A; Saha A; Ghosh SK; Bhat HR; Singh UP
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000363. PubMed ID: 33760298
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs, part III.
el-Gendy Z; Morsy JM; Allimony HA; Ali WR; Abdel-Rahman RM
Pharmazie; 2001 May; 56(5):376-83. PubMed ID: 11400552
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives.
Pomarnacka E; Bednarski P; Grunert R; Reszka P
Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339
[TBL] [Abstract][Full Text] [Related]
48. Role of uncondensed 1,2,4-triazine compounds and related heterobicyclic systems as therapeutic agents--a review.
Abdel-Rahman RM
Pharmazie; 2001 Jan; 56(1):18-22. PubMed ID: 11210661
[TBL] [Abstract][Full Text] [Related]
49. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F
Eur J Med Chem; 2002 Sep; 37(9):709-20. PubMed ID: 12350288
[TBL] [Abstract][Full Text] [Related]
51. Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives.
Sarhan MO; Motaleb MA; Ibrahim IT; Anwar MM; Zaghary WA
Mini Rev Med Chem; 2018; 18(15):1302-1320. PubMed ID: 28971773
[TBL] [Abstract][Full Text] [Related]
52. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
Verma T; Sinha M; Bansal N
Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
[TBL] [Abstract][Full Text] [Related]
53. Discovery of a novel DNA binding agent via design and synthesis of new thiazole hybrids and fused 1,2,4-triazines as potential antitumor agents: Computational, spectrometric and in silico studies.
El-Wakil MH; El-Yazbi AF; Ashour HMA; Khalil MA; Ismail KA; Labouta IM
Bioorg Chem; 2019 Sep; 90():103089. PubMed ID: 31271947
[TBL] [Abstract][Full Text] [Related]
54. Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones.
Sztanke K; Pasternak K; Sztanke M; Kandefer-Szerszeń M; Kozioł AE; Dybała I
Bioorg Med Chem Lett; 2009 Sep; 19(17):5095-100. PubMed ID: 19631534
[TBL] [Abstract][Full Text] [Related]
55. [Antineoplastics 17. Analysis of mono- and disubstituted 2,4-dichloro-5-diethylamino-1,3,5-triazines].
Kreutzberger A; Langner P; Stratmann J
Arch Pharm (Weinheim); 1991 Mar; 324(3):173-6. PubMed ID: 1859252
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of Arylamino-1,3,5-triazines Functionalized with Alkylatin 2-chloroethylamine Fragments and Studies of their Cytotoxicity on the Breast Cancer MCF-7 Cell Line.
Fraczyk J; Kolesinska B; Swiontek M; Lipinski W; Drozdowska D; Kaminski ZJ
Anticancer Agents Med Chem; 2016; 16(11):1435-1444. PubMed ID: 26845131
[TBL] [Abstract][Full Text] [Related]
57. Recent insights into synthetic β-carbolines with anti-cancer activities.
Kumar S; Singh A; Kumar K; Kumar V
Eur J Med Chem; 2017 Dec; 142():48-73. PubMed ID: 28583770
[TBL] [Abstract][Full Text] [Related]
58. 2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity.
Ott GR; Wells GJ; Thieu TV; Quail MR; Lisko JG; Mesaros EF; Gingrich DE; Ghose AK; Wan W; Lu L; Cheng M; Albom MS; Angeles TS; Huang Z; Aimone LD; Ator MA; Ruggeri BA; Dorsey BD
J Med Chem; 2011 Sep; 54(18):6328-41. PubMed ID: 21859094
[TBL] [Abstract][Full Text] [Related]
59. Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR.
Menear KA; Gomez S; Malagu K; Bailey C; Blackburn K; Cockcroft XL; Ewen S; Fundo A; Le Gall A; Hermann G; Sebastian L; Sunose M; Presnot T; Torode E; Hickson I; Martin NM; Smith GC; Pike KG
Bioorg Med Chem Lett; 2009 Oct; 19(20):5898-901. PubMed ID: 19733066
[TBL] [Abstract][Full Text] [Related]
60. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
